Pre-clinical modeling of cutaneous melanoma
Despite the new targeted and immunotherapies for metastatic melanoma, several patients show therapeutic plateau. Here, the authors review the current pre-clinical models of cutaneous melanoma and discuss their strengths and limitations that may help with overcoming therapeutic plateau.
Saved in:
| Main Authors: | Vito W. Rebecca, Rajasekharan Somasundaram, Meenhard Herlyn |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/0003348e52b44f61bda3eaf9e47fe9f7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
by: Jinah Kim, et al.
Published: (2011) -
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
by: Johannes Griss, et al.
Published: (2019) -
Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician
by: Rebecca Adams, et al.
Published: (2021) -
Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study
by: Alessandra Buja, et al.
Published: (2021) -
HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics.
by: Ke-Jun Chen, et al.
Published: (2021)